Table 1.
Diagnostic Tool/Parameters | Diseases | Clinical Applications—“Strengths” | Limitations—“Weaknesses” |
---|---|---|---|
ESE (TRVmax PASP calculation) |
PAH |
|
|
MS | |||
MR | |||
AS | |||
HFrEF | |||
HCM | |||
CPET (VE/VCO2, peak VO2, PETCO2) |
PAH |
|
|
RHC during exercise (mPAP, wPAP) |
MR |
|
|
HFpEF |
AS, aortic stenosis; CPET, cardiopulmonary exercise testing; ESE, exercise–stress echocardiography; HCM, hypertrophic cardiomyopathy; MR, mitral regurgitation; HFpEF, heart failure preserved ejection fraction; HFrEF, heart failure reduced ejection fraction; mPAP, mean pulmonary artery pressure; MS, mitral stenosis; PASP, pulmonary artery systolic pressure; peak VO2, peak oxygen consumption; PETCO2, extrapolated end-tidal carbon dioxide tension; pts, patients; PAH, pulmonary artery hypertension; RHC; right heart catheterization; TRVmax, tricuspid regurgitation maximum velocity; VE/VCO2, ventilation to carbon dioxide production relationship; wPAP, wedge PAP.